These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1679297

  • 1. Longer relapse-free period after sucralfate than after H2-blocker treatment of duodenal and gastric ulcers.
    Domschke S, Domschke W.
    Am J Med; 1991 Aug 08; 91(2A):74S-83S. PubMed ID: 1679297
    [Abstract] [Full Text] [Related]

  • 2. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G, Parente F.
    J Clin Gastroenterol; 1992 Apr 08; 14(3):192-8. PubMed ID: 1348753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE.
    Am Fam Physician; 1986 Nov 08; 34(5):141-4. PubMed ID: 2877559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prevention of ulcer disease].
    Loizeau E.
    Schweiz Med Wochenschr; 1986 Oct 04; 116(40):1371-4. PubMed ID: 2877491
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H, Carling L, Hallerbäck B, Kagevi I, Solhaug JH, Svedberg LE, Wahlby L.
    Scand J Gastroenterol Suppl; 1987 Oct 04; 140():39-47. PubMed ID: 3328284
    [Abstract] [Full Text] [Related]

  • 13. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN, Nio CY.
    Z Gastroenterol; 1987 Aug 04; 25 Suppl 3():152-61. PubMed ID: 3660894
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F, Gottardello L, Germanà B, Dotto P, Grassi SA, Vianello F, Battaglia G, Leandro G, Burra P, Salvagnini M.
    Ital J Gastroenterol; 1992 Aug 04; 24(3):122-5. PubMed ID: 1348650
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ulcer recurrences following initial ulcer healing with sucralfate or cimetidine.
    Solhaug JH, Carling L, Glise H, Hallerbäck B, Hallgren T, Kagevi I, Svedberg LE, Wählby L.
    Scand J Gastroenterol Suppl; 1987 Aug 04; 127():77-80. PubMed ID: 3475770
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM.
    J Clin Gastroenterol; 1990 Aug 04; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [Abstract] [Full Text] [Related]

  • 20. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 04; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.